Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model*
- 1 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 30 (3) , 637-643
- https://doi.org/10.1097/00003246-200203000-00024
Abstract
This study evaluates the effects of heparin alone and in combination with lisofylline, 1-(5-R-hydroxyhexyl)3,7-dimethylxanthine, on severe smoke injury. Prospective animal study with concurrent controls. An animal laboratory. Eighteen 1-yr-old female sheep, weighing 24–32 kg. After smoke exposure and tracheostomy, animals were divided into three groups. Group S (n = 6) received nebulized saline through an endotracheal tube every 4 hrs for 48 hrs. Group H (n = 6) received 10,000 units of nebulized heparin every 4 hrs. Group LH (n = 6) was treated with nebulized heparin and intravenous infusion of lisofylline (10 mg·kg−1·hr−1) for 48 hrs after a bolus injection (20 mg/kg). Animals initially breathed room air spontaneously. If Pao2 was 60 torr, animals were mechanically ventilated. Sheep were killed 48 hrs postinjury. Blood gases were measured serially. At 48 hrs, ventilation perfusion distribution mismatching was analyzed by using the multiple inert gas elimination technique. Lung malondialdehyde was determined. The postinjury increase in alveolar-arterial oxygen tension gradient (LH, 36.7 ± 3.5 vs. S, 89.0 ± 24.6 torr at 48 hrs) was significantly attenuated in those animals receiving LH. The percentage of pulmonary shunt, Qs/Qt (LH, 20.8 ± 4.9 vs. S, 36.6 ± 4.6%), and the percentage of animals that required ventilation (LH, 0 vs. S, 67%) were significantly reduced in LH. Multiple inert gas elimination technique study showed that the true shunt fraction was decreased in LH. Lung malondialdehyde was significantly less in LH (LH, 0.33 ± 0.06 vs. S, 0.56 ± 0.09 nmol/mg protein). There was no significant difference in any of these variables between H and S. Treatment with heparin alone did not attenuate pulmonary dysfunction after severe smoke injury. Combined treatment with nebulized heparin and systemic lisofylline had beneficial effects on pulmonary function in association with a decrease in blood flow to poorly ventilated areas and less lipid peroxidation.Keywords
This publication has 24 references indexed in Scilit:
- Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shockCritical Care Medicine, 1996
- Heparin protection against Fe2+‐and Cu2+‐mediated oxidation of liposomesFEBS Letters, 1996
- The effect of heparin on Cu2+-mediated oxidation of human low-density lipoproteinsFEBS Letters, 1995
- Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice.The Journal of Experimental Medicine, 1995
- Effect of graded increases in smoke inhalation injury on the early systemic response to a body burnCritical Care Medicine, 1995
- THE EFFECT OF INHALED NITRIC OXIDE ON SMOKE INHALATION INJURY IN AN OVINE MODELPublished by Wolters Kluwer Health ,1994
- CT-1501R SELECTIVELY INHIBITS INDUCED INFLAMMATORY MONOKINES IN HUMAN WHOLE BLOOD EX VIVOShock, 1994
- Lipid Peroxides as the Initiating Factor of AtherosclerosisAnnals of the New York Academy of Sciences, 1993
- Dimethylsulfoxide With Heparin in the Treatment of Smoke Inhalation InjuryJournal of Burn Care & Rehabilitation, 1988
- Severity-related Alteration in Cardiopulmonary FunctionAnnals of Surgery, 1987